Drug profile · INN
sebetralstat
EKTERLY
sebetralstat (EKTERLY) is an FDA-listed pharmaceutical active ingredient. Associated with Kalvista Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.
Drug details — sebetralstat
- US status
- approved
- Class
- Blood and blood forming organs (B06)
- Route
- ORAL
- Patents
- 10
- Programs
- 0
- Data quality
- 0.89
Quick answer
sebetralstat (EKTERLY) is an FDA-listed pharmaceutical active ingredient. Associated with Kalvista Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related & competitor drugs
Related patents
-
US 11739068
Polymorphs of N-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide and salts thereof
granted -
US 11234939
Dosage forms comprising a plasma kallikrein inhibitor
granted -
US 11230537
Polymorphs of n-[(3-fluoro-4-methoxypyridin-2-yl)methyl]-3-(methoxymethyl)-1-({4-[2-oxopyridin-1-yl)methyl]phenyl} methyl)pyrazole-4-carboxamide as iallikrein inhibitors
granted -
US 11198691
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
granted -
US 11084809
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
granted -
US 11001578
N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
granted -
US 10611758
N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors
granted -
US 10478409
Pharmaceutical compositions
granted -
US 10364238
N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors
granted -
US 9533987
Heterocyclic derivates
granted
Frequently asked questions
What is sebetralstat?
sebetralstat (EKTERLY) is an FDA-listed pharmaceutical active ingredient. Associated with Kalvista Pharmaceuticals (Ireland) Limited. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for sebetralstat?
EKTERLY is a marketed brand name for sebetralstat. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sebetralstat?
sebetralstat has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.